Dapsone
Paul G. Auwaerter, M.D.
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Leprosy
Dermatitis herpetiformis
Acne vulgaris
(dapsone 7.5% or 5% gel)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Aphthous ulcers, severe
Bullous SLE
Chronic spontaneous urticaria
ITP
PCP
prophylaxis
Pemphigus vulgaris
Pyoderma gangrenosum
Relapsing polychondritis
PCP (with
trimethoprim
)
Treatment of mild to moderately severe PCP
Toxoplasmosis
prophylaxis (with
pyrimethamine
and
leucovorin
) in patients with HIV
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved